 |
 printable version
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries (June 2004):
Previous page |
1,2,3
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries Part 2 | WHO focus country | “3 by 5” treatment target (50% of estimated need) | Antiretroviral therapy target declared by country for end 2005 | Estimated number of people receiving antiretroviral therapy (15-49 years) June 2004 | Antiretroviral therapy coverage | | Angola | 16 000 | 5 500 | 700 | 2.20% | | Belize | 220 | not declared | 29 | 6.60% | | Botswana | 30 000 | 55 000 | 18 000 | 30.00% | | Burkina Faso | 21 500 | 20 000 | 2 000 | 4.70% | | Burundi | 19 000 | 12 500 | 2 186 | 5.80% | | Cambodiac | 14 000 | 12 800 | 3 389 | 12.10% | | Cameroon | 42 500 | not declared | 8 660 | 10.20% | Central African
Republic | 19 500 | not declared | 1 000 | 2.60% | | China | 50 000 | 30 000–50 000 | 7 400 | 7.40% | | Costa Rica | 1 250 | not declared | 1 654 | 66.20% | | Côte d'Ivoire | 39 000 | not declared | 2 025 | 2.60% | Democratic Republic
of the Congo | 80 000 | not declared | 2 500 | 1.60% | | Djibouti | 600 | 1 370 | 94 | 7.80% | | El Salvador | 2 350 | not declared | 1 212 | 25.80% | | Ethiopia | 100 000 | 93 000 | 4 500 | 2.30% | | Ghana | 26 000 | 30 000 | 716 | 1.40% | | Guatemala | 6 000 | not declared | 2 740 | 22.80% | | Guinea | 8 000 | 20 000 | 500 | 3.10% | | Guyana | 1 000 | not declared | 251 | 12.60% | | Haiti | 20 000 | 5 000–10 000 (end 2004) | 1 370 | 3.40% | | Honduras | 3 700 | not declared | 1 421 | 19.20% | | Indiad,e | 355 000 | 100 000 | 21 000 | 3.00% | | Indonesia | 3 550 | 10 000 | 1 500 | 21.10% | | Kazakhstan | 230 | not declared | 49 | 10.70% | | Kenya | 110 000 | 95 000 | 11 000 | 5.00% | | Kyrgyzstan | 24 | not declared | 0 | 0.00% | | Lesotho | 27 000 | 28 000 | 1 000 | 1.90% | | Malawi | 65 000 | not declared | 3 760 | 2.90% | | Mozambique | 95 000 | 21 000 | 2 840 | 1.50% | | Myanmar | 21 000 | 10 000 | 200 | 0.50% | | Namibia | 14 500 | not declared | 400 | 1.40% | | Nicaragua | 465 | not declared | 19 | 2.00% | | Nigeria | 260 000 | 15 000 | 17 000 | 3.30% | | Panama | 1 100 | not declared | 1 530 | 69.50% | | Russian Federationf | 35 500 | not declared | 1 800 | 2.50% | | Rwanda | 18 000 | not declared | 2 140 | 5.90% | | Somalia | NA | not declared | 0 | NA | | South Africa | 375 000 | not declared | 20 000 | 2.70% | | Sudan | 21 500 | 20 000 | 400 | 0.90% | | Swaziland | 16 000 | 12 000 | 3 200 | 10.00% | | Tajikistan | NA | not declared | 0 | NA | | Uganda | 55 000 | 60 000 | 20 000 | 18.20% | | Ukraineg | 22 500 | 2 100 | 170 | 0.40% | United Republic
of Tanzania | 130 000 | 220 000 | 1 650 | 0.60% | | Uzbekistan | 385 | not declared | 0 | 0.00% | | Viet Nam | 11 000 | 15 000 | 1 000 | 4.50% | | Yemen | NA | not declared | 0 | NA | | Zambia | 70 000 | 100 000 | 8 500 | 6.10% | | Zimbabwe | 145 000 | 55 000 | 6 000 | 2.10% |
HIV prevalence, HIV mortality, antiretroviral therapy needs and targets for the 49 "3 by 5" focus countries (June 2004):
1,2,3
|
